Invizius

Invizius is a biotech company. It has 1 recorded funding round, most recently an Extension Round in September 2024.

Last Round
Extension RoundSep 2024
Rounds
1

Indexed holds 1 funding round and 2 investors for this company. The full record is or through the API.

About

Its most recent funding was an Extension Round in Sep 2024. Investors include Mercia Ventures and Calculus Capital.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension RoundSep 2024
GBP 950K

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Invizius on Indexed.vc
<a href="https://indexed.vc/companies/invizius"><img src="https://indexed.vc/api/badge/company/invizius" alt="Invizius on Indexed.vc" width="260" height="76" /></a>